Munin Corporation

Oak Park, IL 60303

SBIR Award Summary

Total Number of Awards 7
Total Value of Awards $1.88MM
First Award Date 05/18/98
Most Recent Award Date 09/15/02

Key Personnel

Last Name Name Awards Contact
Greenspan Jeffrey A Greenspan 7

7 Awards Won

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-01-93
Budget: 09/15/02 - 08/31/03

Description (provided by applicant): Impaired and delayed wound healing are significant problems in diabetics. Furthermore, aging and diabetes together further compound the problem. These observations have created interest in pharmacologic enhancement of healing with growth factors involved in the body?s wound repair process. Clinical trials hav...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 04/01/02 - 11/30/03

Angiogenesis, formation of new blood vessels from cells of preexisting vessels, is essential for progressive tumor growth and metastasis. Therapies aimed at inhibiting tumor angiogenesis hold great promise in cancer treatment. We have proposed (and presented evidence in Phase I) that a specific recently characterized mammalian factor is an excel...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PAR-00-030
Budget: 08/15/01 - 07/31/02

DESCRIPTION: (Applicant's Description) Angiogenesis, formation of new blood vessels, is essential for progressive tumor growth and metastasis. Therapies aimed at inhibiting tumor angiogenesis (and shrinking tumors through nutrient starvation) hold great promise in cancer ...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PAR-00-061
Budget: 06/01/01 - 12/31/02

DESCRIPTION: (provided by applicant) Angiogenesis, formation of new blood vessels, is essential for progressive tumor growth and metastasis. Therapies aimed at inhibiting tumor angiogenesis (and shrinking tumors through nutrient starvation) hold great promise in cancer ...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 04/01/01 - 03/31/02

Angiogenesis, formation of new blood vessels from cells of preexisting vessels, is essential for progressive tumor growth and metastasis. Therapies aimed at inhibiting tumor angiogenesis hold great promise in cancer treatment. We have proposed (and presented evidence in Phase I) that a specific recently characterized mammalian factor is an excel...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 04/07/00 - 03/31/01

Angiogenesis, formation of new blood vessels from cells of preexisting vessels, is essential for progressive tumor growth and metastasis. Therapies aimed at inhibiting tumor angiogenesis hold great promise in cancer treatment. We have proposed (and presented evidence in Phase I) that a specific recently characterized mammalian factor is an excel...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 05/18/98 - 11/17/98

DESCRIPTION: (Adapted from the Applicant's Abstract). This project will examine the ability of a recently described protein, Cyr61, to induce localized vascular neoangiogenesis and to develop assays with which to screen specific inhibitors of this activity. Neoangiogenesis plays a critical role in wound ...